Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qufengzhitong capsule plus methotrexate for rheumatoid arthritis
ChiCTR2100048769Phase 4Not yet recruiting
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Sep 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of qufengzhitong capsule in rheumatoid arthritis (RA) (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoints: C-reactive protein and erythrocyte sedimentation rate. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
qufengzhitong capsule
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR2100048769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048769.